Immunovant to Present at Upcoming Investor Conferences
13 Novembre 2023 - 2:00PM
Immunovant, Inc. (Nasdaq: IMVT),
a clinical-stage immunology company dedicated to enabling normal
lives for people with autoimmune diseases, today announced that
Pete Salzmann, M.D., chief executive officer, will participate in
fireside chats at the following investor conferences:
Stifel 2023 Healthcare Conference on
Wednesday, November 15, 2023, at 1:50 pm ET
Evercore ISI 6th Annual HealthCONx
Conference on Tuesday, November 28, 2023, at 5:05 pm ET
Piper Sandler 35th Annual Healthcare
Conference on Thursday, November 30, 2023, at 11:30 am ET
The fireside chats will be webcast live and can be
accessed at https://www.immunovant.com/investors/news-events. An
archived webcast will be available for a limited time on
Immunovant’s website.
About Immunovant, Inc.Immunovant, Inc. is a
clinical-stage immunology company dedicated to enabling normal
lives for people with autoimmune diseases. As a trailblazer in
anti-FcRn technology, the Company is developing innovative,
targeted therapies to meet the complex and variable needs of people
with autoimmune diseases. For additional information on the
Company, please visit www.immunovant.com.
Contact:Chau Cheng, PhD,
MBAVice President, Investor RelationsImmunovant,
Inc.info@immunovant.com
Jaye Bea SmalleyHead, Patient AdvocacyImmunovant,
Inc.mediarelations@immunovant.com
Grafico Azioni Immunovant (NASDAQ:IMVT)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Immunovant (NASDAQ:IMVT)
Storico
Da Set 2023 a Set 2024